HBCU Meharry Medical College Gets NIH Support to Advance COVID-19 Drug DevelopmentJune 1, 2020 |
by B. Denise Hawkins
This historically Black Meharry Medical College said on Friday that it will get vital research and technical support from the National Institutes of Health (NIH) to advance its development of a drug for patients infected with COVID-19.
For Meharry, this means that MRCV-19, the compound it is developing, can sprint forward to the NIH for preliminary testing, possibly in the coming weeks, said the medical college’s CEO and infectious disease expert Dr. James E.K. Hildreth, to Diverse.